Clinical Trial Update: Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis [NA]

View source ↗

Summary

This clinical trial evaluated the tolerability of inhaled hypertonic saline in infants with cystic fibrosis. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Hypertonic saline inhalation (Hypertonic saline)

Snippet

Sponsor: CF Therapeutics Development Network Coordinating Center | Conditions: Cystic Fibrosis | NA | Status: COMPLETED